Hydrogen

MET proto-oncogene, receptor tyrosine kinase ; Homo sapiens







7 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35227978 Synthesis, bioevaluation and molecular dynamics of pyrrolo-pyridine benzamide derivatives as potential antitumor agents in vitro and in vivo. 2022 Apr 5 1
2 32157572 Synthesis of triazolotriazine derivatives as c-Met inhibitors. 2021 May 3
3 34247323 Type II c-Met inhibitors: molecular insight into crucial interactions for effective inhibition. 2021 Jul 11 1
4 28411455 Identification of 3-substituted-6-(1-(1H-[1,2,3]triazolo[4,5-b]pyrazin-1-yl)ethyl)quinoline derivatives as highly potent and selective mesenchymal-epithelial transition factor (c-Met) inhibitors via metabolite profiling-based structural optimization. 2017 Jul 7 1
5 26944614 Synthesis and antiproliferative activity of 6,7-disubstituted-4-phenoxyquinoline derivatives bearing the 2-oxo-4-chloro-1,2-dihydroquinoline-3-carboxamide moiety. 2016 Apr 1 1
6 27184766 Synthesis, antitumor evaluation and molecular docking studies of [1,2,4]triazolo[4,3-b][1,2,4,5]tetrazine derivatives. 2016 Jul 1 1
7 23403296 Olive secoiridoids and semisynthetic bioisostere analogues for the control of metastatic breast cancer. 2013 Apr 1 1